Germany | BCH-RA-DE-111112 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-111112-3   |   PDF   |   Print   |  
published: 26 Oct 2016 last updated: 05 Nov 2020
General Information
6786-01-0127 (adv. 42010.0127); Summary of the risk assessment of a deliberate release (field trial) of genetically modified potato (Solanum tuberosum L.), lines VR/T18; VR/T21; VR/T23 and amf/T85; amf/T103; amf/T121, issued by the German Competent Authority
EN
18 Sep 2002
Risk assessment details
  • Potato modified for altered amylose content
    | Max Planck Institute for Plant Breeding Research(MPIPZ) | Changes in quality and/or metabolite content (Amylose and amylopectin ratio, Carbohydrates), Resistance to antibiotics (Kanamycin)
  • Potato modified for Potato Leaf Roll Virus resistance
    | Max Planck Institute for Plant Breeding Research(MPIPZ) | Resistance to antibiotics (Kanamycin), Resistance to diseases and pests (Viruses, Potato leaf roll virus (PLRV), Potato virus Y (PVY))
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
1 field site in Germany, for details refer to the German LMO/GMO location register (http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
construct specific PCR-based method
EN
Additional information
-   deliberate release, no placing on the market.
-   field trial, not for human consumption or for feed purposes

-  There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/01/127
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1